Taiwan will soon sign a contract to purchase the drug molnupiravir, which its makers say significantly reduces the risk of hospitalization or death from COVID-19, Health Minister Chen Shih-chung (陳時中) disclosed Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares end up following technical rebound
04/23/2024 05:34 PM - Business
U.S. dollar closes lower on Taipei forex market
04/23/2024 04:12 PM - Society
More Hualien buildings found partially collapsed after quakes
04/23/2024 02:44 PM - Politics
Latest Cabinet appointments: five old faces, one new face (update)
04/23/2024 02:37 PM - Business
Taiwan shares close up 0.97%
04/23/2024 02:11 PM